Identification of Delstrigo:
No description |
Search images on Google Product Monograph
Active Ingredients:
- doravirine, 100 MG
- lamivudine, 300 MG
- tenofovir disoproxil fumarate, 300 MG
DIN: 02482592
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Schedule: Prescription
Company: MERCK CANADA INC – official site
ATC:
- J05 - ANTIVIRALS FOR SYSTEMIC USE (ATC, WHO, Wiki)
- J05A - DIRECT ACTING ANTIVIRALS (ATC, WHO)
- J05AR - Antivirals for treatment of HIV infections, combinations (ATC, WHO)
- J05AR24 - LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 30
External Links for Delstrigo:
Search on Google
- Delstrigo side effects
- Delstrigo dosage
- doravirine side effects
- doravirine dosage
- lamivudine side effects
- lamivudine dosage
- tenofovir disoproxil fumarate side effects
- tenofovir disoproxil fumarate dosage
Merck Canada Inc
Go to Merck website to see drug product details. Sometimes you can find delstrigo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.